Multiple sclerosis. Multiple sclerosis
Conditions
Interventions
Intervention 1: Control group: In this group, only botulinum toxin injection with BTX-A was performed for the patient under the standard protocol, for this purpose, 100-200 mU of Botox type A, Dysport
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Definitive diagnosis of multiple sclerosis based on the opinion of a neurologist Presence of spasticity in the cuff muscles (based on a score of more than 1 on the modified Ashworth scale (MAS) consent to participate in the study
Exclusion criteria
Exclusion criteria: Having cognitive disorders (in advanced stages of the disease) Having myopathy or peripheral nerve disease Having a pace maker Pregnancy Pre-injection of botulinum toxin during the last 6 months Having cuff muscle atrophy Having coagulation disorders History of previous surgery or fracture at the site of spastic muscles
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before, immediately, 2 weeks and 8 weeks after the intervention. Method of measurement: Visual Analogue Scale (VAS).;Spasticity score. Timepoint: Before, immediately, 2 weeks, and 8 weeks after the intervention. Method of measurement: Modified Ashworth's Scale (MAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShila Haghighat
Esfahan University of Medical Sciences
Outcome results
None listed